Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
444.71
+1.55 (+0.35%)
Streaming Delayed Price
Updated: 12:06 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
72
73
Next >
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
↗
June 15, 2024
Want peace of mind about your investments? Consider these great stocks.
Via
The Motley Fool
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress
June 14, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Should Quality-Oriented Investors Explore VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)?
↗
June 12, 2024
Why NASDAQ:VRTX Stands Out as a Quality Stock.
Via
Chartmill
2 Healthcare Stocks to Buy Hand Over Fist in June
↗
June 12, 2024
They both have pretty impressive pasts, and their prospects look just as bright.
Via
The Motley Fool
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
June 11, 2024
Via
Benzinga
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
↗
June 05, 2024
Via
Benzinga
This Is What Whales Are Betting On Vertex Pharmaceuticals
↗
June 03, 2024
Via
Benzinga
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
↗
June 10, 2024
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.
Via
Talk Markets
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
↗
June 09, 2024
These companies could generate explosive growth over time.
Via
The Motley Fool
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
↗
June 07, 2024
Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .
Via
Benzinga
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®
June 07, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Analyst Expectations For Vertex Pharmaceuticals's Future
↗
May 31, 2024
Via
Benzinga
While growth is established for NASDAQ:VRTX, the stock's valuation remains reasonable.
↗
May 29, 2024
NASDAQ:VRTX is showing decent growth, but is still valued reasonably.
Via
Chartmill
2 Biotech Stocks to Buy in May
↗
May 25, 2024
You could buy these in any month, really.
Via
The Motley Fool
Large Cap BIopharmaceuticals Overview
↗
June 03, 2024
As a defensive play healthcare is weighted at about 12% of the S&P 500.
Via
Talk Markets
Topics
Stocks
3 No-Brainer Stocks to Buy in June
↗
June 02, 2024
Now is the time to invest in these great stocks.
Via
The Motley Fool
5 Top Stocks to Buy in June
↗
June 02, 2024
This medley of growth, value, and income stocks is poised to thrive long-term, even if the stock market sells off this summer.
Via
The Motley Fool
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
↗
June 01, 2024
Eli Lilly is in a buy zone, while rival Novo Nordisk forged a lower entry.
Via
Investor's Business Daily
Topics
Stocks
A Very Bullish Reversal Produces A Huge Batch Of Actionable Stocks
↗
May 31, 2024
It is very hard to get excited about what I'm seeing in the stock market because things have not been the way I've wanted them to be. In this video, I want to show you something as we look at a monthly...
Via
Talk Markets
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
↗
May 23, 2024
Via
Benzinga
Vertex Stock Recently Hit All-Time High, Leads 8 Top Performers New To IBD Stock Lists
↗
May 31, 2024
Vertex stock was one of a select group of eight that made it onto IBD top-stocks lists Friday. The big pharma is near its all-time high.
Via
Investor's Business Daily
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
↗
May 30, 2024
Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat.
Via
The Motley Fool
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
↗
May 28, 2024
Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung function.
Via
Benzinga
Got $500? 3 Pharma Stocks to Buy and Hold Forever
↗
May 26, 2024
These players might even beat the market when the conditions are right.
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
↗
May 26, 2024
Shares of the growing biotech company have doubled in three years.
Via
The Motley Fool
3 High-Flying Stocks That Could Soar Even More
↗
May 25, 2024
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.
Via
The Motley Fool
SLB, First Solar And 2 Other Stocks Insiders Are Selling
↗
May 23, 2024
Via
Benzinga
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
↗
May 23, 2024
Walmart Inc. reported a "really strong" quarter, with e-commerce sales surging 21%. Adjusted EPS was 60 cents.
Via
Benzinga
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now
↗
May 23, 2024
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy.
Via
InvestorPlace
Vertex to Participate in Upcoming June Investor Conferences
May 22, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
